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Abstract
Enzootic strains of Venezuelan equine encephalitis virus (VEEV) have been isolated from febrile patients in the Peruvian
Amazon Basin at low but consistent levels since the early 1990s. Through a clinic-based febrile surveillance program, we
detected an outbreak of VEEV infections in Iquitos, Peru, in the first half of 2006. The majority of these patients resided
within urban areas of Iquitos, with no report of recent travel outside the city. To characterize the risk factors for VEEV
infection within the city, an antibody prevalence study was carried out in a geographically stratified sample of urban areas
of Iquitos. Additionally, entomological surveys were conducted to determine if previously incriminated vectors of enzootic
VEEV were present within the city. We found that greater than 23% of Iquitos residents carried neutralizing antibodies
against VEEV, with significant associations between increased antibody prevalence and age, occupation, mosquito net use,
and overnight travel. Furthermore, potential vector mosquitoes were widely distributed across the city. Our results suggest
that while VEEV infection is more common in rural areas, transmission also occurs within urban areas of Iquitos, and that
further studies are warranted to identify the precise vectors and reservoirs involved in urban VEEV transmission.
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Introduction
Members of the Venezuelan equine encephalitis virus (VEEV)
complex are arboviruses belonging to the Alphavirus genus of the
Togaviridae family. First identified among equines in the 1930s [1],
VEEV-associated human disease was not recognized until 1943
[2,3] , although epidemiological data suggest that outbreaks may
date back to the 1920s [4]. VEEV subtypes cause a wide clinical
spectrum of disease ranging from undifferentiated fever to severe
neurological symptoms, with a case fatality rate of 1–4% [5]. Two
transmission cycles have been identified: an enzootic cycle,
maintained among rodent reservoirs in forest habitats, and an
epizootic cycle that causes high rates of mortality in horses as well
as epidemics among human populations [4]. These cycles are
typically associated with distinct subtypes of the VEE virus
complex: subtypes IAB and IC with equine epizootics, subtypes
ID, IF, and II–VI with the equine avirulent enzootic cycle [4,6],
and subtype IE with both enzootic and equine-virulent transmis-
sion cycles [7,8,9]. Despite disparate serological and clinical
phenotypes some enzootic and epizootic subtypes are highly
genetically conserved. In particular, strains of the enzootic subtype
ID (Columbia/Venezuela genotype) show less than 0.5%
divergence from epizootic IAB and IC subtypes at the amino
acid level [10,11,12]. Based on this genetic conservation, epizootic
strains have been proposed to emerge periodically from progenitor
strains continuously maintained in an enzootic forest cycle.
Accordingly, a single amino acid change within the E2 envelope
gene has been shown to confer an epizootic phenotype on an
enzootic VEEV strain [10,11,12,13].
Geographically, members of the VEEV antigenic complex have
been restricted to tropical and sub-tropical regions of the Western
Hemisphere, with VEEV complex isolates reported from Argen-
tina through the southern United States. The majority of human
VEEV infections have occurred during large outbreaks in Central
America and northern South America, most notably in Colombia
and Venezuela [14,15]. In Peru, multiple human epidemics and
equine epizootics have occurred on the Pacific coastal plain,
possibly due to introduction of epizootic virus from Ecuador. At
present, all evidence suggests that the epidemiology of VEEV on
the west coast of Peru has been associated exclusively with the
epizootic subtype IAB [3,16,17,18]. In contrast, in the Amazon
Basin to the east of the Andean mountains VEEV isolates have
been restricted to enzootic ID, IIIC, and IID subtypes. The first
cases of human VEEV infection in this region were reported in
1994 when Peruvian Army personnel were deployed to an area
near Iquitos [18,19]. Human VEEV cases have been documented
near Iquitos continuously since then [6,19] (TJK, unpublished
data). Based on entomological studies carried out in the nearby
village of Puerto Almendras and the Otorongo Military Base from
1996–2001 [20], mosquitoes from the Culex (Melanoconion) group
www.plosntds.org 1 December 2008 | Volume 2 | Issue 12 | e349have been incriminated as the local sylvatic VEEV vector in rural
areas, consistent with results from Panama, Colombia, and
Venezuela [4,5,21,22,23]. While potential vectors of enzootic
VEEV have also been periodically detected within urban
neighborhoods [24,25], the possibility for urban transmission of
enzootic VEEV has not been systematically addressed. The city of
Iquitos represents the interface between the Amazon forest and a
densely populated urban environment, and therefore a potential
bridge between enzootic transmission cycles and potential
peridomestic urban transmission.
In 1990, the Naval Medical Research Center Detachment
(NMRCD) initiated a clinic-based surveillance program to
determine the etiologies of febrile illness within Iquitos as well as
nearby villages. Herein we report evidence of a 2006 outbreak of
febrile illness associated with enzootic VEEV infection detected by
the NMRCD surveillance program. Following the outbreak, a
seroprevalence survey was carried out in three Iquitos neighbor-
hoods where acute human cases were identified as well as in a
control neighborhood where acute cases were not reported during
the 2006 outbreak. Additionally, a series of mosquito collections
were conducted both during and after the outbreak to characterize
potential urban VEEV vectors. The primary objective of this
article is to evaluate the evidence for peri-domestic VEEV
transmission within the city of Iquitos, Peru.
Materials and Methods
Study Site
The study was conducted in the Loreto Department in Peru in
the city of Iquitos located 120 meters above sea level in the
Amazon forest (73.2uW, 3.7Su). This site has been described in
detail previously [24,25,26,27,28]. Briefly, Iquitos is a geograph-
ically isolated population within the Amazon forest, accessible only
by river or air travel. The major industries of Iquitos are small
business, fishing, oil, lumber, tourism and some agriculture [27].
The climate is tropical, with an average daily temperature of 25uC
and year-round precipitation totaling 2.7 meters. Daily temper-
ature and precipitation data for 2000–2006 from a weather station
located at the Iquitos airport were retrieved from http://lwf.ncdc.
noaa.gov/cgi-bin/res40.pl?page=climvisgsod.html (Figure S1).
River levels surrounding the city change dramatically due to
runoff from the eastern side of the Andes mountains, increasing by
up to 10 m (108–118 m) between the ‘‘vaciente’’ (May–Novem-
ber) and ‘‘creciente’’ (December–April) [29]. Information for daily
river levels was obtained from the local water plant (Figure S1).
Serological and entomological surveys described in the study
were initially targeted to three areas of Iquitos based on the
residences of VEEV-infected patients detected through a clinic-
based surveillance system during 2006 (Figure 1). The neighbor-
hoods included in this study were Bella Vista Nanay (San Pedro,
Nuevo Bellavista, Accio ´n Cato ´lica, Nuevo Amanecer, and San
Valentı ´n) located in the northern-most section of the city; Bele ´n,
located in the eastern part of the city along the Itaya River; and
three sites along Avenida Participacio ´n in the San Juan District
(Las Mercedes, San Pablo de la Luz, and 26 de Febrero). Common
attributes of the Bella Vista, Bele ´n, and San Juan sites include
seasonal flooding, and proximity to rivers, lowland humid tropical
forest, and open farmland. The area surrounding Iquitos has
experienced varying degrees of deforestation, but patches of both
primary and secondary growth trees are found on opposite banks
of the three surrounding rivers. The habitat observed in all three
neighborhoods is rather homogeneous. Species diversity, including
a wide variety of aquatic plants (Onagraceae, Pontederiaceae, Araceae
families) and abundance was highest in the Avenida Participacio ´n
neighborhoods, followed by Bella Vista Nanay, and finally Belen
which had the highest density of housing and port activity (Table
S1 for species list). The Bella Vista site is seasonally flooded by the
blackwater Nanay River, whereas the Belen and San Juan sites are
located on the silty and sediment-rich whitewater Itaya River. The
Allpahuayo National Reserve and ‘‘Ell Huayo’’ Botanic Garden
are located ,25 km to the south of the city where both feral
mammalian and forest mosquito species have been well charac-
terized [30,31].
In addition to the three neighborhoods with active VEEV cases
during 2006, we obtained blood samples from residents in
designated a control area where no increase in VEEV activity
was detected. This area included 22 blocks in north central parts of
Iquitos where previous dengue studies had been conducted (ACM,
unpublished data). This geographically diverse group of blocks was
easily accessible to our research team because of our previous
studies there, and represented a contrast to the 3 study
neighborhoods. Overall, these control neighborhoods were of
higher socio-economic condition [29] (Morrison unpublished data)
and located several blocks from the river whereas the other study
areas were adjacent to the river. Municipal records obtained from
‘‘La asociacio ´n de viviendas inundables y desarrollo humano de
Punchana’’ and ‘‘El Programa de Emergencia Social Productivo
Urbano’’ indicate that the neighborhoods in BellaVista Nanay and
Avenida Participacio ´n (‘‘New’’) were all established since 1998–
2003 whereas the Belen and control blocks (‘‘Old’’) have been
registered since 1943 and have existed prior to that date.
Study Design
We will present data from 3 separate studies. First we will
describe a bimodal outbreak of febrile illness attributed to VEEV
infection that began in 2005 and culminated with a significant
increase in cases in the first half of 2006. This notable increase in
human cases stimulated NMRCD to carry out a cross-sectional
seroprevalence study in three neighborhoods where VEEV cases
had been detected within the city limits of Iquitos, as well as a
series of entomological studies to document the abundance of and
Author Summary
Venezuelan equine encephalitis (VEE) is a mosquito-borne
viral disease often causing grave illness and large
outbreaks of disease in South America. In Iquitos, Peru, a
city of 350,000 situated in the Amazon forest, we normally
observe 10–14 VEE cases per year associated with people
traveling to rural areas where strains VEE virus circulate
among forest mosquitoes and rodents. In 2006 we
detected a 5-fold increase in human VEE cases, and many
of these patients had no travel history outside the city
where they lived. In response to this outbreak, we decided
to determine if potential carrier mosquitoes were present
within the city and if city residents had been previously
exposed to the virus. We found that mosquitoes previously
shown to transmit the virus in other locations were
present—in varying amounts based on location and time
of year—throughout Iquitos. A large percentage of the
human population (.23%) had antibodies indicating past
exposure to the virus. Previous VEE infection was
associated with age, occupation, mosquito exposure, and
overnight travel. Our data represent evidence of transmis-
sion of a forest strain of VEE within a large urban area.
Continued monitoring of this situation will shed light on
mechanisms of virus emergence.
VEEV Transmission in Urban Peru
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describe in detail the methods associated with each sub study.
Febrile Surveillance Study
Since 2000, NMRCD has been conducting syndromic surveil-
lance in 11 Government Health Centers and Hospitals (9 urban
and 2 rural). This study, entitled ‘‘Surveillance and Etiology of
Acute Febrile Illness,’’ was approved by the NMRCD Institutional
Review Board (NMRCD.2000.0006). Trained health workers are
stationed in each location 0700-1300. All acute, undifferentiated,
febrile illness cases (i.e. temperature greater than or equal to 38uC
for 7 days duration or less) seen by a health center physician were
referred first to the national Malaria program where they are
tested for Malaria by a thick smear and then to our surveillance
program. For inclusion into the study, in addition to fever, patients
needed to report one or more of the following symptoms:
Figure 1. Map of Iquitos showing the locations of the 4 major study areas. The neighborhoods where active VEE cases were identified are
shown in grey and the study blocks are shown in black. Study blocks in the dengue study area (white background) are also shown in black. The
blocks where routine entomological surveys were carried out between January 2006 and January 2007 are shown in black and white stripes.
doi:10.1371/journal.pntd.0000349.g001
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cough; nausea; vomiting; sore throat; rhinorrhea; difficulty
breathing; diarrhea; bloody stools; jaundice; dizziness; disorienta-
tion; stiff neck; petecchiae; ecchymoses; bleeding gums or nose.
Children younger than five years of age were included if they
presented with hemorrhagic manifestations indicative of dengue
hemorrhagic fever (DHF), including bleeding gums or nose,
petecchiae, bloody stool or hematemesis. Written informed
consent was obtained from adults greater than 18 years of age.
For minors, written consent was obtained from parents, and assent
was obtained from participants ages 8–17. For participants unable
to read and sign the consent form, a witness was present to testify
to oral consent. Demographic data, residential address, medical
history, and clinical features for each patient were obtained using a
standard questionnaire. During the acute phase of illness blood
samples were obtained from each patient, and when possible,
convalescent samples were obtained 10 days to 4 weeks later for
serological studies. In addition, axial temperature, blood pressure,
and respiratory rate were recorded, and in most facilities a
tourniquet test was performed. Exclusion criteria included a clear
focus of infection (i.e. respiratory, gastrointestinal, urinary tract).
Acute and convalescent samples were tested for a range of
arboviruses including VEEV. Diagnoses were considered con-
firmed if they met the following criteria: clinical diagnosis along
with laboratory confirmation (isolation of virus from the sample,
identification by RT-PCR, or 4-fold increase in IgM antibody
titers). Patients’ residences were located using existing GIS data for
Iquitos [26] and confirmed by study team members.
Serological Surveys
In response to the notable increase in VEE cases observed in
early 2006, serological surveys were initiated in three neighbor-
hoods with high VEEV activity between January–June 2006 and
on blocks that had participated in a previous dengue cohort study
(22 city blocks located in 7 geographic zones) located in the
districts of Maynas, San Juan and Punchana. Surveys were
conducted between early November and mid-December of 2006.
The post-outbreak study protocol was reviewed and approved by
the NMRCD Institutional Review Board (PJT.NMRCD.001).
Trained phlebotomists (10–22 in total) working in two person
teams were assigned individual maps and proceeded door to door
to explain the study and recruit participants. Participation was
offered to all individuals $5 years of age. If the residents agreed to
participate, the consent and assent forms were signed before
samples were obtained. Written informed consent was obtained
from participants older than 18 years, and from parents of
participants younger than 18. In addition, assent was obtained
from participants 8–17 years of age. If participants were unable to
read and sign the consent form, oral consent was obtained and
documented in the presence of a witness. Each participant was
asked a series of questions about their homes, as well as travel
histories and illnesses during the previous year. Younger children
(,14 years) were interviewed with their parents. Blood samples
were obtained using standard aseptic techniques using a
vacutainer tube and 21–23 gauge needles. All blood samples were
tested for anti-VEEV antibodies using IgG and IgM ELISAs. All
samples that tested positive by IgG ELISA were further evaluated
for anti-VEEV antibodies by the plaque reduction-neutralizing
test (PRNT).
Entomological survey
Two adult mosquito collection methods were used for this study.
First, standard household surveys were carried out as previously
described [24,25]. In these surveys adult mosquitoes were collected
using a backpack aspirator both inside and outside the house.
Mosquito collections were concentrated in areas with high
numbers of human VEEV cases during the 2006 outbreak.
Second, CDC light traps baited with CO2 were placed outdoors
between 1800-0600 h on four continuous nights in Bella Vista
Nanay, Belen and in San Juan neighborhoods of Las Mercedes,
San Pablo de la Luz and 26 de Febrero. Adult mosquitoes were
identified to species [32] on dry ice and sorted into plastic vials by
species for storage at 270uC for later testing for VEEV RNA by
RT-PCR.
Laboratory Assays
Virus isolation and identification. Acute-phase serum
samples from febrile patients were diluted 1:5 in minimum
essential medium containing 2% heat-inactivated fetal bovine
serum and antibiotics and subsequently inoculated onto African
Green Monkey Vero (37uC) and mosquito (Aedes albopictus) C6/36
(28uC) cell cultures [33]. Upon observation of viral cytopathic
effect, or ten days post-inoculation if no CPE was observed, cells
were removed from the flasks and placed on 12-well glass spot-
slides for examination by immunofluoresence assay (IFA) using
anti-VEEV polyclonal antibodies. Viral RNA was extracted from
VEEV-positive cultures, amplified by reverse transcriptase-PCR
(RT-PCR) and sequenced, as described elsewhere [6,34].
IgG and IgM ELISA. Participants’ sera were assayed for IgG
and IgM antibodies against VEEV antigen (VEEV VR69 ATCC)
by ELISA as previously described using a VEEV (vaccine strain
TC-83 subtype IAB) lysate antigen from Vero cells [35,36]. The
positive cutoff optical density (OD) value was calculated from the
mean adjusted OD of antibody negative control sera plus 3
standard deviations.
Plaque Reduction Neutralization Test (PRNT). PRNT
protocol was modified from Morens et al. (1985) [37]. Briefly,
participants serum was heat-inactivated at 56uC in a water bath
for 30 minutes and diluted in media (Eagle’s Minimal Essential
Medium [EMEM] + Penicillin/Streptomycin [Pen./Strep]) from
1:10 to 1:500. VEEV (subtype IAB vaccine strain TC83
TVB5215) was diluted to contain 15 plaques/well in 24-well
TC-plate. The viral dilution was mixed in equal volume of the
participant’s serum and incubated at 4uC overnight. The serum-
virus mixture was subsequently inoculated onto a monolayer of
Vero-76 cells in 24-well plates (seeded with 0.5 ml/well of 3610
5
cells/ml) and incubated at 37uCi n5 %C O 2 for 3 hours. 0.5 ml
overlay media (0.6% Carboxymethyl Cellulose, Minimum
Essential Medium [MEM] without Phenol Red, 10% Fetal
Bovine Serum [FBS], 0.075% NaHCO3 and Pen/Strep) was
added to the wells and incubated for 3 days. On day three media
was removed, and the cells rinsed with H2O and stained with
0.5 ml/well stain solution (0.1% (w/v) Naphthol Blue Black,
1.36% (w/v) Sodium Acetate, and 6% (v/v) Glacial Acetic Acid)
for 30 min. The stain was then removed and the plaques where
counted. The results were expressed as the serum dilution,
determined by probit analysis that reduced the number of
plaques by 70% compared to that of normal human serum at
the same dilution. The conditions used in determining PRNT
titers (70% plaque reduction and inverse titer cutoff of 60) were
based on experiments performed to optimize sensitivity and
specificity of the VEEV PRNT in our laboratory. The potential for
cross-reaction due to prior infection by co-circulating alphaviruses,
such as Mayaro virus, necessitated a higher cutoff level than used
elsewhere [38].
RT-PCR analysis of mosquito homogenates. Mosquitoes
collected by CDC light traps were tested for VEEV RNA using
RT-PCR modified from Lanciotti et al. (2000) [39]. Briefly,
VEEV Transmission in Urban Peru
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subsequently homogenized. Viral RNA was then extracted and
purified using QIAamp viral RNA kit (QIAGEN, Valencia, Calif.).
Primers sequences were specific for VEEV subtypes ID and III
[6,34]: V8369 (GAGAACTGCGAGCAATGGTCA) and
V9207B(-) (TRCACTGGCTGAACTGTT) for subtype ID, and
V8369 and V9257B(-) (TACACCCAYTTRTCRTTCTG) for
subtype III.
Statistical analysis
Proportions were compared using a chi-square test using the
FREQ procedure in SAS (SAS Version 8, 1999, SAS Institute
Inc., Cary, NC.). Risk factors for infection with VEEV were
evaluated by logistic regression using LOGISTIC in SAS. Models
were constructed with the dichotomous dependent variable:
PRNT positive for VEEV antibody at a titer of $1:60 and the
following independent variables: age (adult, child), occupation,
travel history (report of multiple day trips outside Iquitos), and
animals (on property).
Results
Evidence for VEE Outbreak
From 2000–2004 the NMRCD febrile surveillance program
detected up to four VEEV cases per month with annual totals
ranging from 10–14 cases (Table 1). In 2005, however, 15 cases
were identified in June and July, with an annual total of 27. Fifteen
of these cases came from rural clinics Zungaracocha (10 cases) and
Quistococha (5 cases). An additional five cases came from Hospital
Apoyo, which serves patients from the entire Department of
Loreto; three of these five maintained residence outside of Iquitos.
In 2006, there were 63 confirmed cases of VEEV infection
captured in the febrile surveillance study (Table 1), representing a
5-fold increase in the number of cases from the 2000–2004
average. Of these 63 cases, 29 were identified by IgM
seroconversion, and 34 were identified by IFA and RT-PCR.
The partial PE2 nucleotide sequence was determined for a subset
of the viral isolates and compared to previously characterized
VEEV strains; all sequenced isolates were found to belong to the
enzootic Panama/Peru ID subtype (Figure S2), closely related to
previous isolates from the region [6].
Of the 63 cases detected in 2006, 60 were detected from
February to July, with the peak occurring in April and May. In
both 2005 and 2006, VEEV activity was concentrated during the
first half of the year, as river levels were increasing to a peak in
April and May. Precipitation levels were higher during January–
March in both 2005 and 2006 when compared to 2000–2004 and
in 2006 river levels were higher than previous years. Sixty of the
VEEV-infected individuals reported to public health centers, and
three were Peruvian Navy personnel reporting to a military health
center. Health facilities in Belen, Bella Vista Nanay and San Juan
were the urban centers with the highest 6-year and 2006 VEEV
case totals (Table 1). The demographic information and travel
history of the civilian cases observed in 2006 are summarized in
Table 2, with comparison to other febrile patients reporting to
public health centers during the same year. No statistically
significant differences were found between VEEV patients and
other patients in gender, travel history, or occupation (data not
shown). Compared with other febrile patients, a higher percent of
VEEV patients reported residences outside of urban Iquitos
(Table 2; x
2=10.2, df=1,P,.005). Despite this bias, the majority
of VEEV patients resided within the city (44, 73.3%) and did not
report history of travel within the 30 days preceding their illness
(53, 88.3%).
Seroprevalence Survey
Population sampled. In response to the 2006 VEEV
outbreak, a seroprevalence survey was conducted in
neighborhoods within Iquitos. A total of 1,327 participants were
enrolled from November 2 to 30, 2006. Of these, 13 were not
included in the analysis due to inconclusive serological results
(insufficient sera for PRNT); 11 were participants from the control
blocks and 1 each from Belen and Bella Vista Nanay. The mean
age of the 1,314 evaluated subjects was 29 years (range 5–88
years); 70.7% (920) were adults ($18 years old); and 67% (880)
were female (Table 3). Most of the respondents (99.9%) claimed to
be permanent residents of Iquitos, with only 17.5% (230) reporting
multi-day trips outside Iquitos and 24.9% (327) reporting day
excursions (Table 3). The most common occupation reported was
housewife (561, 42.7%), followed by student (418, 31.8%) and
merchant/vendor (107, 8.1%). Only 26 (1.8%) individuals
reported occupations considered to be at high risk for exposure
to a forest VEEV cycle (fisherman, or laborer working in
agriculture, the petroleum industry, or logging/lumber).
Among the respondents, 33.9% reported fever, body aches and
headache (listed as ‘‘syndrome’’ in Table 3) in the previous six
months. Reports of febrile syndrome were highest in Bella Vista
Nanay and San Juan (Table 3; x
2=11, df=3, P=0.0104). Eleven
participants reported loss of consciousness in conjunction with
febrile syndrome; three of these also reported convulsions during
the previous six months.
Study population characteristics by
neighborhood. Characteristics of the study population by
neighborhood are shown in Table 3. Females participated at a
higher rate than males, and adults more often than children; this
pattern was consistent across neighborhoods (x
2=8.9, df=7,
P=0.26; x
2=4.5, df=3, P=0.20, respectively) with the exception
of the control blocks (106 of 304, 34.9%) which had a higher
proportion of minors (,18 years; 288 of 1010, 28.5%; x
2=4.5,
df=1, P=0.034). Participants reporting occupational exposure to
forest environments were low overall. Belen had the highest (3.8%)
proportion of participants in high exposure occupations whereas
Table 1. Laboratory confirmed cases of VEEV infection
identified in 11 health facilities in or near Iquitos, Peru.
Health Center Surveillance Year Total
2000 2001 2002 2003 2004 2005 2006
Bella Vista Nanay 0170111 0 20
S a n A n t o n i o 0000240 6
Clinical Naval - 100013 5
Hosp. Apoyo Iquitos 1000458 18
S a n t a R o s a - 201000 3
M o r o n a c o c h a 0101116 10
T u p a c A m a r u 0260105 14
Belen 1112101 7 23
S a n J u a n 8008005 21
Quistococha* ----1 5 6 12
Zungarococha 120231 0 3 21
Total 11 10 14 14 14 27 63 153
Note: centers listed in bold are located in rural areas outside Iquitos.
*Site was activated in 2004.
doi:10.1371/journal.pntd.0000349.t001
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2=10.3, df=3,
P=0.0164).
In the control blocks 64.8% of the houses were made with
concrete or brick compared with 8.7% to 19.8% in the
neighborhoods reporting active VEEV cases (x
2=351, df=3,
P,0.0001). Use of mosquito nets by residents was high overall
(86%) but varied by neighborhood (x
2=154, df=3, P,0.0001).
Domestic animals (dogs, cats, chickens, and pigs) were more
prevalent in the control areas (82.2%) than the VEEV blocks
(61.6%) (x
2=44, df=1, P,0.0001). In contrast, rodents were
Table 2. Demographic information of VEEV febrile patients and all other febrile patients reporting to public health centers in 2006.
Characteristic Subcategory VEEV Cases All Febrile Cases
No. Acute Cases 60 1136
Sex Male 32 (53.3%) 531 (46.7%)
Female 28 (46.7%) 605 (53.3%)
Median Age (Range) 23.5 (6–71) 24 (1–82)
Recent Travel 7 (11.7%) 197 (17.6%)
Residence outside Iquitos 16 (26.7%) 141 (12.4%)
Occupation Student 19 (31.7%) 349 (30.7%)
Housewife/Work from Home 16 (22.3%) 335 (29.5%)
Vendor/Merchant 7 (11.7%) 97 (8.5%)
Laborer 4 (6.7%) 43 (3.8%)
Agriculture 3 (0.5%) 18 (1.6%)
Other 11 (18.3%) 294 (25.8%)
doi:10.1371/journal.pntd.0000349.t002
Table 3. Characteristics of 1,314 subjects living in three neighborhoods reporting VEEV cases between January and June, 2006,
and 22 blocks previously included in Dengue cohort studies.
Neighborhood
Gender
(Males)
Age (,18
years)
Occupation
(High Risk)
Travel
(Yes)
Excursion
(Yes)
Animals
(Yes)
House
(Noble)
Mosquito
Net (Use)
Syndrome
(Yes)
Belen 126 97 13 57 78 193 34 253 113
(36.5%) (28.1%) (3.8%) (16.5%) (22.6%) (55.9%) (9.9%) (73.3%) (32.8%)
Bella Vista
Nanay
94 94 5 65 119 182 28 316 119
(29.2%) (29.2%) (1.6%) (20.2%) (37.0%) (56.5%) (8.7%) (98.1%) (37.0%)
San Pedro 32 26 3 27 40 52 11 89 34
(35.6%) (28.9%) (3.3%) (30.0%) (44.4%) (57.8%) (12.2%) (98.9%) (37.8%)
Nuevo Bellavista 27 40 1 21 37 74 12 118 43
(22.9%) (33.9%) (0.9%) (17.8%) (37.4%) (62.7%) (10.2%) (100%) (36.4%)
AC/SV/NA 35 28 1 17 43 56 5 110 42
(30.4%) (24.4%) (0.9%) (14.8%) (37.4%) (48.7%) (4.4%) (95.7%) (36.5%)
San Juan 109 97 7 65 64 247 68 334 132
(31.8%) (28.3%) (2.0%) (19.0%) (18.7%) (72.0%) (19.8%) (97.4%) (38.5%)
Las Mercedes 43 26 3 28 33 110 56 125 44
(33.9%) (20.5%) (2.4%) (22.1%) (26.0%) (86.6%) (44.1%) (98.4%) (34.7%)
San Pablo 51 49 3 36 29 103 12 160 34
(30.5%) (29.3%) (1.8%) (21.6%) (17.4%) (61.7%) (7.2%) (95.8%) (37.8%)
26 de Febrero 15 22 1 1 1 34 0 48 32
(31.3%) (45.8%) (2.1%) (2.1%) (2.1%) (70.8%) (0.0%) (100%) (66.7%)
Control 105 106 1 43 66 250 197 227 82
(34.5%) (34.9%) (0.3%) (14.1%) (21.7%) (82.2%) (64.8%) (74.7%) (27.0%)
TOTAL 434 394 26 230 327 872 327 1130 446
(33.0%) (29.3%) (1.8%) (17.5%) (24.9%) (66.4%) (24.9%) (86%) (33.9%)
The 4 major neighborhoods are indicated in bold, whereas areas within each neighborhood are indicated in normal text.
doi:10.1371/journal.pntd.0000349.t003
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Vista Nanay (90.7%), followed by San Juan (82.8%) and control
neighborhoods (79.6%) (x
2=48, df=3,P,0.0001).
Participants were asked about trips and excursions they had
taken in the previous 6-month period. The questions were
designed to distinguish between longer (overnight trips) and short
day trips to recreational areas near Iquitos. Participants reporting
longer versus shorter trips ranged from 14–20% and 19–37% of
the respondents, respectively. The majority of the trips reported
were to river communities or recreation areas within the Amazon
Basin.
Antibody prevalence analysis. Participant samples were
initially screened by VEEV-specific IgG ELISA and subsequently
confirmed by PRNT. Of the 1,314 participants included in the
analysis, 71.8% (943) tested negative and 28.2% (371) tested
positive for anti-VEEV antibodies by IgG ELISA (Table 4).
Following the initial screening, 313 (23.8% of the total samples) of
the 371 IgG-positive samples also had VEEV neutralizing
antibodies at a titer of $1:60. Of these, 28 had titers between
1:60 and 1:98, 122 were between 1:101 and 1:495, 118 were
between 1:500 and 1:2402, and 45 were greater than 1:2560. Of
the 1136 samples, only three had positive IgM antibody titers
against VEEV.
Antibody prevalence rates varied between neighborhoods, but
were highest in San Pedro and Nuevo Bellavista located in Bella
Vista Nanay (37–41%) and 26 de Febrero (38%) located in San
Juan, followed by Las Mercedes and San Pablo in San Juan (26–
30%; Table 4). Despite the high number of VEEV cases reported
from Belen in 2006, antibody prevalence rates were similar to
those in the control area, which had reported fewer VEEV cases
that year. The neighborhoods in Belen and the control
neighborhoods are older than those in San Juan and Bella Vista
Nanay. Thus, the major contrast was between older neighbor-
hoods where 18.5% of participants had antibody to VEEV
compared to newer neighborhoods with rates of 29% (x
2=20,
df=1,P,0.0001).
Risk factors. Gender, day travel, presence of domestic
animals, rodent sightings on the property, and the type of house
construction materials had no association with VEEV antibody
prevalence in our study sample (Table 5). Variables associated
with VEEV antibody positivity in univariate logistic regression
analysis included age, occupation, extended overnight travel,
mosquito net use, and history of febrile illness syndrome (fever,
body aches, headache) in the previous six-month period (Table 5).
VEEV antibody positivity increased with age, with clear
neighborhood differences (Figure 2). Antibody prevalence rates
were higher among 10–29 year-old subjects in the BellaVista
Nanay and San Juan neighborhoods (34%), compared to the Belen
and control neighborhoods (24%; x
2=8.6, df=1, P=0.0033).
Even though only 26 sample participants reported a high-risk
occupation, this group had higher odds of VEEV infection than all
other occupations combined (OR=4.5, 95% CI 2.1, 10.0).
Individuals reporting overnight travel outside Iquitos also had
higher odds VEEV infection, but, interestingly, not those reporting
day trips. It is probable that there was some confusion between the
two questions for respondents. The Spanish terms ‘‘Viaje’’ (trip)
and ‘‘Paseo’’ (excursion) are often interchangeable. To address
this, we combined both categories into a single variable; in
combination, travel was not significantly associated with VEEV
antibody response (Table 5), indicating risk was only associated
with overnight travel further from the city . Mosquito net use and
history of febrile illness were both associated with previous VEEV
infection. There were more reports of febrile illness in the areas
with higher antibody prevalence rates (Table 5), perhaps reflecting
the recent VEEV activity detected in the passive febrile
surveillance system.
Multivariate logistic regression was performed, evaluating all
demographic and potential risk factor variables described above in
a stepwise fashion with VEEV antibody prevalence as an outcome
variable. The neighborhood variable was collapsed into older
(Belen and control blocks) and newer (Bella Vista Nanay and San
Juan) areas. All risk factors identified in the univariate analysis
remained in the final model. The adjusted odds ratios are shown in
Table 6.
Entomological Surveys
Backpack aspirator mosquito collections (January 2006–
January 2007) near control blocks. As part of ongoing studies
of dengue vector epidemiology, our NMRCD/UC Davis study
team carried out standardized Aedes aegypti surveys at
Table 4. Prevalence of anti-VEEV antibodies among 1,314 subjects living in 4 neighborhoods in Iquitos, Peru.
Neighborhood* No. Samples IgG (2)I g G ( +) All (-)
PRNT (2) PRNT (+)
Belen 345 258 (74.8%) 26 (10.6%) 61 (17.7%) 284 (82.3%)
Bella Vista Nanay 323 201 (62.2%) 23 ( 7.1%) 99 (30.7%) 224 (69.3%)
San Pedro 90 45 (50.0%) 8 (8.9%) 37 (41.1%) 53 (59.9%)
Nuevo Bellavista 118 66 (55.9%) 8 (6.8%) 44 (37.3%) 74 (62.7%)
AC/SV/NA 115 90 (78.3%) 7 (6.1%) 18 (15.7%) 97 (84.3%)
San Juan 342 239 (69.9%) 9 ( 2.6%) 94 (27.5%) 248 (72.5%)
Las Mercedes 127 91 (71.7%) 3 ( 2.4%) 33 (26.0%) 94 (74.0%)
San Pablo 167 118 (70.7%) 6 ( 3.6%) 43 (25.7%) 124 (74.3%)
26 de Febrero 48 30 (62.5%) 0 ( 0.0%) 18 (37.5%) 30 (62.5%)
Control 304 245 (80.6%) 0 ( 0.0%) 59 (19.4%) 245 (80.5%)
Total 1,314 943 (71.8%) 58 (4.4%) 313 (23.8%) 1,001 (76.2%)
*Neighborhoods in bold print are shown in Figure 1 and represent totals for housing areas listed below. Belen, Bella Vista Nanay and San Juan neighborhoods reported
VEEV cases between January–June, 2006 in clinic-based passive febrile surveillance studies. The control areas consist of 22 blocks previously included in Dengue cohort
studies.
doi:10.1371/journal.pntd.0000349.t004
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geographic zones. Mosquitoes captured during backpack
aspirator collection were identified to genera. Culex species from
both the Culex and Melanoconion sub-genera were commonly
collected inside houses during the day. In addition, specimens
from the genera Psorophora, Uranotaenia, Mansonia, and Ochlerotatus
were commonly observed. The number of Culex (Cx.) spp. ranged
from 2–675 adults per hectare surveyed, whereas Culex (Mel.) spp.
Figure 2. Age-dependent increase of VEEV-neutralizing antibodies.
doi:10.1371/journal.pntd.0000349.g002
Table 5. VEEV antibody prevalence by potential risk factors for infection and odds ratio in univariate logistic regression.
Variable Category Percent Prevalence (No. Positive/No Tested) OR (95% CI)
Gender Female 23.2 (204/880) 0.90
Male 25.1 (109/434) (0.69–1.18)
Age ,18 years 14.7 (58/394) 2.22
$18 years 27.7 (255/920)* (1.62–3.04)
Occupation High Risk 57.7 (15/26)* 4.53
Low Risk 23.1 (298/1288) (2.06–9.97)
Neighborhood Old (Belen/Control) 18.5 (120/649) 1.80
New (BellaVista/San Juan) 29.0 (193/665)* (1.39–2.34)
Travel (Multi-day) Yes 31.3 (72/230)** 1.59
No 22.2 (241/1084) (1.17–2.18)
Travel (Day trip) Yes 22.9 (75/327) 0.94
No 24.1 (238/987) (0.64–1.26)
Travel (Multi or 1 day) Yes 26.6 (130/488) 1.28
No 22.2 (183/826) (0.98–1.65)
Animal Yes 25.1 (219/872) 1.24
No 21.3 (94/442) (0.94–1.63)
Rodent Sightings Yes 25.3 (271/1148) 0.91
No 23.6 (42/166) (0.63–1.33)
Mosquito Net Use 25.5 (288/1130)** 2.18
Don’t Use 13.6 (25/184) (1.40–3.39)
Housing Materials Wood 21.1 (69/327) 0.81
Concrete/Brick 24.7 (244/987) (0.60–1.10)
Febrile Syndrome Yes 29.2 (130/446)** 1.54
No 21.1 (183/868) (1.86–2.00)
*P,0.0001 by x
2 test.
**P,0.005 by x
2 test.
doi:10.1371/journal.pntd.0000349.t005
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(Figure 3). Abundance levels showed both geographic and
temporal differences; most notably Culex (Mel.) spp. population
levels appeared highest during our April 2006 surveys and were
clearly highest during the first half of the year (Figure 3). These
collections were not designed to monitor population abundance of
these species in a systematic way, rather to illustrate that these
species are present and can reach high population densities in
urban areas of Iquitos. No routine surveys were carried out the
Bella Vista Nanay, San Juan, or Belen areas during the first half of
2006 when VEEV activity was detected in the febrile surveillance
program. Between February 17 and March 17, routine collections
were carried out in the same MOH zone as the Belen
neighborhood (Figure 1); 152 Culex (Cx.) spp., 13 Culex (Mel) spp.,
and 8 other non-Aedes species were observed per hectare surveyed.
Post-outbreak mosquito collections. To more
systematically address the presence of potential VEEV vectors in
neighborhoods with high numbers of VEEV cases, in October
2006 both household and CDC light-trap surveys were conducted
on the blocks corresponding to the serological survey. Overall,
mosquito abundance levels were consistent with those observed in
other parts of the city at that time of year, but were lower than
those observed during the first half of 2006 (Table 7).
A total of 12,065 mosquitoes were collected from 208 CDC light
trap-nights baited with CO2 during September and October.
Genera collected include Aedeomyia, Aedes, Anopheles, Coquillettidia,
Culex, Mansonia, Ochlerotatus, and Uranotaenia (Table 8). There was
an average of 58 mosquitoes per trap-night observed in the five
neighborhoods sampled. The highest number captured (160
mosquitoes/trap-night) was in the neighborhood 26 de Febrero
located on the Avenue La Participacio ´n, near the Iquitos-Nauta
Highway on the edge of urban Iquitos. The lowest number (1.7
mosquitoes/trap-night) was captured in Belen. The other
neighborhoods located in San Juan, Las Mercedes and San Pablo
de la Luz had intermediate mosquito densities of 47 mosquitoes
per trap-night. Finally, in Bella Vista Nanay 17 mosquitoes were
captured per trap-night. The most common species observed (72%
of total captured mosquitoes) in each of the sampled neighbor-
hoods was Culex quinquefasciatus, a cosmopolitan species with a
worldwide distribution, especially in urban areas. In this study,
1,276 specimens (11%) were from the Culex (Mel.) group. Culex
(Mel.) ocossa was the most abundant Melanoconion species previously
implicated as a principal VEE vector, whereas Psophora cingulata and
Table 6. Adjusted odds ratios of potential risk factors
associated with VEEV antibody status, based on a stepwise
multivariate logistic regression model.
Independent Variables Odds Ratio 95% CI
Age (referent, child) 2.13 1.54–2.93
Travel (referent, no history of travel) 1.43 1.03–1.98
Neighborhood (referent, older neighborhoods) 1.53 1.16–2.02
Occupation (referent, low risk) 3.44 1.52–7.80
Febrile Syndrome (referent, none) 1.46 1.12–1.92
Mosquito Net (referent, Don’t Use) 1.88 1.17–3.02
doi:10.1371/journal.pntd.0000349.t006
Figure 3. Population densities of mosquitoes collected during household entomological surveys. Mosquitoes were collected with
backpack aspirators in house-to-house daytime surveys, carried out in 50 blocks distributed among 10 Ministry of Health zones. Results are
represented as the mean (6std error) of the number of mosquitoes collected per hectare surveyed. The other species category includes mosquitoes
from the following genera: Aedomyia, Coquillitidea, Psorophora, Uranotaenia, Mansonia, Ochlerotatus, and Wyeomia.
doi:10.1371/journal.pntd.0000349.g003
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vectors observed [40,41]. All female mosquitoes collected were
homogenized and tested for VEEV RNA by RT-PCR. All
specimens tested were negative.
Discussion
Based on data from a clinic-based febrile illness surveillance
program, transmission of enzootic VEEV subtypes has been well
documented in the Iquitos area of northeastern Peru at consistent
but low levels since the early 1990s [6,19,42]. In this study we
report an outbreak of human VEEV infections during the first half
2006 detected through the NMRCD surveillance program, with
the majority of patients residing within city limits. In response to
this outbreak, we conducted an antibody prevalence study and
mosquito collections within urban areas of Iquitos, targeting
neighborhoods with large numbers of cases during the 2006
outbreak. The prevalence of VEEV antibody exceeded 18% in all
areas, and known vectors of the disease were identified across the
city. To our knowledge, this is the first antibody survey for
enzootic VEEV in an urban population.
Enzootic subtypes of VEEV have been thought to be
maintained primarily in sylvatic cycles of tropical and sub-tropical
forests. Consistent with this idea, we found acute VEEV infection
to be more common among febrile patients residing outside of
Iquitos, adjacent to the rain forest. Furthermore, we found multi-
day travel and forest-related occupations to be statistically
significant risk factors for VEEV antibody positivity. However,
while transmission may be higher in rural areas, several lines of
evidence suggest that transmission occurs within the urban areas of
Iquitos as well. First, while forest-related occupation was a
significant risk factor, these occupations comprised only a very
small percentage of the total. In previous studies, enzootic VEEV
clinical disease has been most frequently reported in adult males
due to this association with high-risk forest occupations [43]. In
contrast, we found no correlation in this study between gender and
VEEV antibody status or acute VEEV infection. Second,
consistent with prior reports [6], the majority of the acute human
cases detected in the passive surveillance program maintained
residence within the city proper and did not report recent travel.
Third, nearly 70% of VEEV-antibody positive survey respondents
did not report recent travel, and day trips were not strongly
associated with antibody positivity. It should be noted that our
study might underestimate respondents’ exposure to the forested
zones surrounding Iquitos, as recall bias is likely a limitation in
obtaining accurate travel history information. Furthermore, our
antibody prevalence study did not adequately control for
migration into the city. Specifically, we did not determine the
length of residence at the current address for study participants or
the location of previous residence. Especially in older age groups,
infection before establishing residence in Iquitos must be
considered. Despite these limitations, the existing information
suggests that some level of VEEV transmission occurs within
urban Iquitos.
While our data suggest that enzootic VEEV strains are
transmitted in urban areas, the exact mechanism is unclear. One
possibility is the existence of a self-perpetuating endemic cycle
established within urban Iquitos. Alternatively, urban cases of
enzootic VEEV may be caused by repeated introductions of the
virus from local forests, either by infected vectors or by infected
hosts. Enzootic VEEV has been isolated from spiny rats (Proechimys
spp.) in the region [6]; however, within the city limits of Iquitos
rodent fauna appears to be mostly limited to Rattus ratus, Rattus
norvegicus and mus musculus [44]. Iquitos is geographically isolated
within the Amazon forest, and the distances between natural forest
cycles and the city may well be within the natural home range of
vectors and reservoirs. Within 20 km of the city there is a diversity
of mammalian fauna, including rodents (Proechimys spp., Oryzomys
spp., Neacomys spp. , and Dasyprocia spp.), marsupials (Phliander spp.,
Marmosops spp., Micoureus spp., Caluromys spp., Metachirus spp., and
Monodelphis spp.), bats (Platyrihinus spp., Artibeius spp., Sturnira spp.,
and Carollia spp.) and sloths (Choloepus spp. and Bradypus spp.) In
addition to sylvatic rodents, various species of waterfowl are
readily infected by enzootic VEEV [41,45]. Such birds, if found to
be amplifying reservoirs, could quickly expand the geographic and
ecological distribution of the virus. Delineating the precise
mechanism of urban transmission will require identification of
relevant vectors and reservoir hosts currently infected and
circulating within the city.
Mosquitoes from the Culex (Mel.) species have been previously
implicated as the primary vectors of enzootic subtypes of VEEV
[40,46,47]. In this study, we found that Culex (Mel.) species are
present throughout the city and abundant at certain times of the
year. Most notably, Cx. (Mel.) ocossa, the vector of ID VEEV in
Panama [41], was observed in significant numbers. We have also
identified the presence of other genera within urban Iquitos that
have been previously incriminated as potential vectors for enzootic
VEEV. For example, in our study blocks we detected Psorophora
(especially cingulata), Mansonia and Coquillettidia species, which have
been shown to be competent vectors in the laboratory [48,49].
Additionally, Aedes aegypti has been shown to be a competent vector
of both enzootic [50] and epizootic VEEV in the laboratory
Table 7. Number of adult mosquitoes collected per hectare in house-to-house backpack aspirator collections carried out in
October 2006.
Neighborhood Culex (Cx) Culex (Mel) Psorophora Uranotaenia Mansonia Others
Belen 28 1.28 0.0 0.0 0.0 0.0
Bella Vista Nanay 124.62 0.79 0.0 0.52 0.0 0.0
San Pedro 8.85 0.0 0.0 0.0 0.0 0.0
Nuevo Bellavista 144.71 0.92 0.0 0.61 0.0 0.0
San Juan 233.7 15.76 2.49 3.11 0.62 0.21
Las Mercedes 318.08 10.12 6.74 1.12 0.00 0.56
San Pablo 162.29 20.39 0.0 5.52 1.27 0.00
26 de Febrero 259.72 14.51 0.0 0.00 0.00 0.00
doi:10.1371/journal.pntd.0000349.t007
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feeding preference, as well as temporal and spatial distribution,
argues against a role for Aedes aegypti in VEEV transmission cycles
in Iquitos, the possibility warrants further examination. In the
current study, we tested a wide range of mosquito species collected
from CDC traps for the presence of VEEV RNA. We were unable
to detect VEEV in any of the mosquito species tested; however,
these studies were conducted at least four months after the last
Table 8. Mosquitoes collected in CDC Light traps in neighborhoods with clinical cases of VEEV infection in 2006.
Species
Bella Vista
Nanay San Juan (Av. La Participacio ´n) Bele ´n Total
Las Mercedes
San Pablo de
Luz 26 de Febrero
Ad. (Ady.) squamipennis 1 11 205
Ae. (Stg.) aegypti 0 07 301 0
An. (Nys.) sp 0 00 101
An. (Nys.) triannulatus 0 10 001
Cq. (Rhy.) hermanoi 0 01 102
Cq. (Rhy.) nigricans 0 15 701 3
Cq. (Rhy.) venezuelensis 21 9 7 4 3 0 7 1
Cx. (Ads.) amazonensis 5 0 18 45 0 68
Cx. (Cx.) corniger 0 00 011
Cx. (Phe.) corniger 7 00 211 0
Cx. (Cx.) coronator 17 26 13 27 4 87
Cx. (Cx.) declarator/mollis 27 157 126 28 2 340
Cx. (Cx.) quinquefasciatus 255 1054 1531 5786 45 8671
Cx. (Cx.) sp 18 90 178 589 1 876
Cx. (Mel.) adamesi [22] 0 01 102
Cx. (Mel.) atratus G r o u p 0 01 001
Cx. (Mel.) declarator/mollis 0 02 002
Cx. (Mel.) dunni 0 03 003
Cx. (Mel.) gnomatus [40,43] 0 00 101
Cx. (Mel.) ocossa [41,22] 56 12 86 687 1 842
Cx. (Mel.) pedroi [40,22] 1 13 1 8 12 4
Cx. (Mel.) portesi [41,22] 1 03 1 2 01 6
Cx. (Mel.) sp* 49 29 74 163 14 329
Cx. (Mel.) spissipes [22] 0 01 001
Cx. (Mel.) theobaldi 2 41 0 001 6
Cx. (Mel.) vomerifer[40,22]5 2 1 3 1 7 2 3 9
Ma. (Man.) amazonensis 3 1 1 0 001 4
Ma. (Man.) flaveola 0 00 011
Ma. (Man.) humeralis 1 9 00 102 0
Ma. (Man.) indubitans/titillans [40] 48 20 26 104 2 200
Ma. (Man.) pseudotitillans 1 10 103
Oc. (Och.) fulvus 1 00 001
Oc. (Och.) hastatus 0 01 001
Ps. (Gra.) cingulata [40] 1 58 102 58 0 219
Ps. (Jan.) albigenu [40] 6 00 107
Ur. (Ura.) apicalis 20 3 1 4 1 2 0
Ur. (Ura.) gemetrica 0 10 203
Ur. (Ura.) hystera 0 1 44 46 2 93
Ur. (Ura.) iowii 2 9 14 164 1
Ur. (Ura.) pallidoventer 0 07 119
Ur. (Ura.) sp 0 00 101
Citations are provided for species previously implicated as vectors (shown in bold).
*Undescribed species for Peruvian Amazon.
doi:10.1371/journal.pntd.0000349.t008
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Furthermore, in previous studies VEEV infection rates in
mosquitoes have been found to be very low [16,20]. Turell et
al., for example, recovered 25 VEEV isolates from 245,053 Culex
(Mel.) spp. specimens [20]. In that study, 14 of 25 VEEV isolates
were from Culex (Mel.) gnomatos; in our study, only one Culex (Mel.)
gnomatos specimen was collected. To clearly define urban
transmission patterns within Iquitos, prospective studies of
potential vectors, including VEEV isolation and abundance
pattern characterization, are needed during seasons of high
incidence.
Irrespective of species, there is compelling indirect evidence
linking mosquito exposure within the city to prior VEEV infection.
First, Bella Vista Nanay and San Jaun had higher mosquito
abundance in both household surveys and CDC light-trap
collections than the two neighborhoods with lower seroprevalence
rates. Furthermore, mosquito net use was significantly more
common in neighborhoods with higher seroprevalence than in
those with lower seroprevalence rates. The fact that mosquito-net
use was a risk factor for previous infection VEEV may seem
counterintuitive, but it is also a proxy for intensity of exposure to
mosquito bites. In areas where biting intensity is higher more
individuals use nets out of necessity. This association needs to be
interpreted in the context of the specifics of mosquito net use (eg.
the precise time of day that are people protected) and condition.
Many respondents mentioned bathing in the river at sunset; Culex
mosquitoes are crepuscular and thus would have access to people
during the dusk hours regardless of nighttime mosquito net use.
Overall, it is clear that exposure to potential mosquito vectors
occurs in all areas of the city, but this evidence indicates that
exposure is highest in the areas with the highest seropositivity.
The cause for the 2006 outbreak of VEEV infections is unclear.
It is interesting to note that the 2006 outbreak inside the city was
preceded by a spike in cases just outside the city in 2005. There are
several possibilities that might explain both increases. Vector
abundance may have increased due to cyclical weather patterns,
increasing rates of transmission in the forest, with a subsequent
urban spillover. Furthermore unusually high annual river levels
occurring in early 2006 may have increased competent vectors
within the city (i.e., Cx. (Mel.) ocossa) leading to the observed urban
VEEV cases. Alternatively, human encroachment on forest areas,
due to activities such as agriculture and logging, may have
increased human contact with established enzootic transmission
cycles and altered vector and reservoir distribution. Mutations in
circulating sylvatic viruses might have led to greater potential for
human infection and disease, and thus an increase in clinical cases.
In light of the genetic similarity between enzootic and epizootic
strains of VEEV, the possibility of humans as productive hosts, as
well as the potential for emergence of an epidemic strain in urban
areas, needs to be considered.
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